VYNE Therapeutics Inc.
About VYNE Therapeutics Inc.
VYNE Therapeutics is a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immunological (I&I) conditions with high unmet need.
Led by a proven and resourceful team of drug developers, VYNE is applying scientific innovation to advance novel therapies that have the potential to improve the lives of millions of people afflicted by autoimmune diseases. The catalyst of the company’s differentiated approach is its proprietary InhiBET Platform that potentially unlocks a promising new drug target for improving the treatment of challenging I&I diseases with significant unmet medical needs.
BETs are a family of proteins that are believed to play a causal role in the regulation of inflammatory genes that are implicated in numerous diseases. VYNE has done the first formative work in applying BET inhibition to the treatment of autoimmune disease. The company’s leadership is demonstrated in clinical development, where VYNE is building a superior body of evidence that informs the advancement of its two lead product candidates: VYN201 for the treatment of vitiligo; and VYN202, a highly potent and selective BET inhibitor that offers promise across a broad array of chronic autoimmune indications.
To learn more about us and our pipeline, visit vynetherapeutics.com.
Read our Social Media Guidelines here: https://vynetherapeutics.com/social-media-guidelines/.
Find VYNE Therapeutics Inc. Execs' Valid Emails
Up to 90% verified emails and mobile numbers, refreshed weekly.
Company Details
10M-25M
Biotechnology Research
11-50 employees
Public Company
Bridgewater, NJ
United States
Frequently Asked Questions about
What is VYNE Therapeutics Inc.'s industry?
VYNE Therapeutics Inc. operates in the Biotechnology Research industry and is headquartered in United States.
How many employees does VYNE Therapeutics Inc. have?
VYNE Therapeutics Inc. has approximately 11-50 employees employees.
Where is VYNE Therapeutics Inc.'s based?
VYNE Therapeutics Inc. is based in Bridgewater, NJ, United States.
Is VYNE Therapeutics Inc. publicly listed?
Yes. VYNE Therapeutics Inc. is a publicly traded company.
How can I contact VYNE Therapeutics Inc.'s investor relations team?
You can reach VYNE Therapeutics Inc.’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.